New diabetes clinical trial: Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Published on: July 17, 2019 at 07:00PM
Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus
Interventions:   Drug: Lantus Solostar, 100 Units/mL Subcutaneous Solution;   Drug: Insulin RinGlar, 100 Units/mL Subcutaneous Solution
Sponsor:   Geropharm
Completed